Compagnie Gervais Danone

Biopolis, S.l.

Ferring B.v.

Universidad Complutense De Madrid

Naturex

Daniel Ramon Vidal

Salvador Genoves Martinez

Gianfranco Grompone

Patricia Martorell Guerola

Beatriz Casinos Ramo

Maria Empar Chenoll Cuadros

Nuria Gonzalez Martinez

Esther Bataller Leiva

Angela Silva Angulo

Ma Empar Chenoll Cuadros

Isabelle Chambaud

Marie-Christine Degivry

Raphaëlle Bourdet-Sicard

Sophie Legrain-Raspaud

Agusti Montserrat Carreras

Silvia Llopis Pla

Patricia Guerola Guerola

Alejandro Montesinos Paes

Marta Tortajada Serra

Victoria Eugenia Santos Mazorra

Miguel Ladero Galan

Felix Garcia-Ochoa Soria

Vanessa Ripoll Morales

Alberto Rodriguez Martín

Josefa Ortiz Serrano

Amaya Aleixandre

Begoña Muguerza Marquínez

Silvia Segarra Manzano

Honorato Monzo Oltra

Natalia Alepuz Rico

Salvador Genoves Martínez

Montserrat Andreu Corominas

Antonia Maria Rojas Martinez

Maria Enrique López

Pepe Ortiz Serrano

David Garcia Valcarce

Vanesa Robles Rodriguez

Salvador GENOVÉS Martinez

ÁNgela Silva Angulo

Alberto RODRÍGUEZ MARTÍN

Legrain-Raspaud Sophie

A novel lactic acidbacterium suitable for treatment of e.g. bacterial vaginosis.

bacterium for treatment of e.g. bacterial vaginosis

The present invention discloses strains ofandwhich have a capacity to degrade gliadin peptides involved in coeliac disease and which peptide degrading activity is stable under low pH and in the presence of mammalian digestive enzymes. These strains are suitable in a product for use in prevention and/or treatment of celiac disease.

Lactic acid bacteria for coeliac disease

The invention relates to the use ofstrain CNCM 1-3690 for reducing body fat accumulation and treating disorders resulting therefrom, such as overweight, obesity, and obesity-related disorders.

[object Object]

The invention relates to a method for producing 2,3-butanediol using improved strains of, and to novel mutant strains obtained by random mutagenesis from the bacterial speciesCECT843, that can be used in the industrial production of 2,3-butanediol from glycerol. The invention preferably relates to thestrains designated IA1 and IIIA3 and deposited in the Spanish Type Culture Collection (CECT) under deposit number CECT8158 (corresponding to the strain designated IA1) and deposit number CECT8159 (corresponding to the strain designated IIIA3). The invention also relates to a method for producing 2,3-butanediol from glycerol by means of a biotechnological process using the novel strains of the invention.

The present invention relates to obtaining bioactive peptides from plant raw materials, specifically cocoa extracts, by means of enzyme treatment. Said biopeptides have angiotensin converting enzyme (ACE) and prolyl endopeptidase enzyme (PEP) inhibitory activity in vitro and/or antioxidant activity in vivo, being able to be used in the food, dietetic and pharmaceutical industry.

Obtaining cocoa extracts rich in bioactive peptides with ACE and PEP enzyme inhibitory activity

The present invention relates to a method usingfor screening of food grade bacteria which have a protective effect against oxidative stress.

Method for selecting bacteria with anti-oxidant action

Growing community of inventors

La Eliana, Spain

Daniel Ramon Vidal